11 Jun

As Chief Business Officer, Jonathan Andrus leads Clinical Ink’s solution management & compliance teams to help sponsors and CROs better leverage eSource, eCOA and ePRO data. With 20+ years of experience, Mr. Andrus brings extensive expertise developing eClinical services that integrate data and technology to help life science…

11 Jun

Lisbeth has been a GCP and pharmacovigilance inspector at the Danish Health and Medicines Authority since 2006. Prior to that, she has experience from the authority perspective on regulatory affairs and as an assessor of clinical trial protocols (1993-1999), from a research and hospital perspective (Clinical pharmacology at…

11 Jun

Kassa Ayalew

  • By panos /

Kassa Ayalew, M.D., M.P.H., serves as Branch Chief for Good Clinical Practice Assessment Branch at the Division of Clinical Compliance Evaluation in the Office of Scientific Investigation at Center for Drug Evaluation and Research (CDER) in FDA. Dr. Ayalew oversees verification of the integrity of efficacy and safety…